View in EDS

ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results.

Saved in:
Bibliographic Details
Title: ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results.
Authors: Cox, Timothy M.1, Drelichman, Guillermo I.2, Cravo, Renata3, Balwani, Manisha4, Burrow, Thomas Andrew5, Martins, Ana Maria6, Lukina, Elena7, Rosenbloom, Barry E.8, Ross, Leorah H.9, Angell, Jennifer9, Peterschmitt, M. Judith9
Source: Molecular Genetics & Metabolism. Feb2015, Vol. 114 Issue 2, pS33-S34. 1p.
Database: Academic Search Ultimate
Description
ISSN:10967192
DOI:10.1016/j.ymgme.2014.12.058